1. Home
  2. DNOW vs SLS Comparison

DNOW vs SLS Comparison

Compare DNOW & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

N/A

Current Price

$15.30

Market Cap

2.9B

Sector

Industrials

ML Signal

N/A

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

N/A

Current Price

$11.28

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DNOW
SLS
Founded
1862
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.7B
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
DNOW
SLS
Price
$15.30
$11.28
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$18.75
★ $32.50
AVG Volume (30 Days)
1.8M
★ 5.0M
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.00
EPS
N/A
★ N/A
Revenue
★ $2,648,000,000.00
N/A
Revenue This Year
$79.68
N/A
Revenue Next Year
$7.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 25.68
N/A
52 Week Low
$10.94
$1.39
52 Week High
$17.26
$15.88

Technical Indicators

Market Signals
Indicator
DNOW
SLS
Relative Strength Index (RSI) 40.72 49.35
Support Level $12.60 $10.82
Resistance Level $16.49 $15.77
Average True Range (ATR) 0.42 0.75
MACD -0.08 0.02
Stochastic Oscillator 0.87 79.10

Price Performance

Historical Comparison
DNOW
SLS

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: